Cogent Biosciences Completes $345 Million Common Stock Offering and $200 Million Convertible Notes Offering

Leila Ahmed North America Legal Chronicle
Tagged:

Gibson Dunn has represented Cogent Biosciences, Inc., Mintz has advised the underwriters. Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here